Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.
about
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-upIntensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerAnalysis of Geometric Shifts and Proper Setup-Margin in Prostate Cancer Patients Treated With Pelvic Intensity-Modulated Radiotherapy Using Endorectal Ballooning and Daily Enema for Prostate ImmobilizationOverview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer.Molecular and functional imaging for detection of lymph node metastases in prostate cancer.FROGG high-risk prostate cancer workshop: patterns of practice and literature review: part I: intact prostate.Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes.A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes.A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume.Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines.Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes.Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results.A retrospective analysis of the prognosis of prostate cancer patients with lymph node involvement on MR lymphography: who might be cured.Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients.Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.[Radiotherapy with rectangular fields compared to conformal fields. Fewer clinical failures in high-risk prostate cancer patients].Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer.Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients.Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of life.Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy.
P2860
Q33582598-D1EA5709-70C6-4FE1-A669-0993D38932FBQ35037541-9D90EC82-B88F-4E7F-984D-B8D0CF26A6A0Q36259082-481D48F4-A047-40BD-9E67-3CD1481C7758Q36471474-708CFFFB-2B31-4B36-B802-9C668984E0ABQ36478072-7E7F6A71-78EE-498A-9FB1-CB569B2272A5Q36520539-7F1077AE-5A6A-4C3F-A4E2-6FA095C5B764Q37154093-4C0EE11F-CCD1-4FB9-AAEF-7EC046149230Q38119113-424622B8-2ABF-4AFF-A32A-C376CC23581EQ38168635-CB5911BD-37AC-42FC-A66B-32BED73C481FQ38392956-86AF55C5-FBD2-4844-BC8A-ABA0C31A1E98Q38399316-DB3356E0-74D3-458E-9208-C0D7A85A2582Q38640375-8885AE9D-DB5B-45B9-B8B0-2A21060CAEBEQ39198017-F7897558-864D-43C4-8510-3CEEE8A41660Q39491384-76E42D4C-3E7F-4AE5-8801-0F6387881D2EQ40990362-B1381A8A-7387-472A-977E-29BC318E8B0CQ41148205-F55D4F6C-E763-41CE-9330-D9B4FE33779AQ41898795-6AF3C296-971B-4D6C-9E9B-ACAC550A4177Q42544341-8DEAD330-1645-4001-9EF3-B7DDA95AE89BQ42687909-0D2B982B-897C-434D-9E19-04E2F086A1B3Q45342738-B9A5CB1E-8199-4171-91BC-090C14D592F5Q46638638-BF57EC48-F2AD-4745-A935-32623B9869FCQ47802807-AC65B3DA-E7D9-455A-9835-07729520A06FQ48075929-1E2595B5-FBF1-40AC-B12B-3316F9F7E633Q48269659-1D60C199-976E-4C80-BAFD-17A1AD075E59Q48271324-2E988C6B-7AEF-4108-A09D-C003C5053260Q50002077-ED2E404D-5A6C-4D76-9B2F-4CB45B23779AQ50231169-01263707-57B9-4CFD-998F-CCC3E0D9FB83Q52405922-52409866-7343-46EA-ADE6-4CACFAD13B2E
P2860
Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@en
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@nl
type
label
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@en
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@nl
prefLabel
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@en
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@nl
P1476
Pelvic nodal radiotherapy in p ...... ionale, and future directions.
@en
P2093
Lisa K Morikawa
P356
10.1016/J.IJROBP.2010.11.074
P407
P50
P577
2011-05-01T00:00:00Z